Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: RECTAL NEOPLASMS - THERAPY , . Treffer: 18

2021

Scheipner, L; Smolle, MA; Barth, D; Posch, F; Stotz, M; Pichler, M; StÖger, H; Gerger, A; Riedl, JM The AST/ALT Ratio Is an Independent Prognostic Marker for Disease-free Survival in Stage II and III Colorectal Carcinoma.
Anticancer Res. 2021; 41(1):429-436 Doi: 10.21873/anticanres.14792
Web of Science PubMed FullText FullText_MUG

 

2019

Marcuello, M; Vymetalkova, V; Neves, RPL; Duran-Sanchon, S; Vedeld, HM; Tham, E; van Dalum, G; Flügen, G; Garcia-Barberan, V; Fijneman, RJ; Castells, A; Vodicka, P; Lind, GE; Stoecklein, NH; Heitzer, E; Gironella, M Circulating biomarkers for early detection and clinical management of colorectal cancer.
MOL ASPECTS MED. 2019; 69(9): 107-122. Doi: 10.1016/j.mam.2019.06.002 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Beets, G; Sebag-Montefiore, D; Andritsch, E; Arnold, D; Beishon, M; Crul, M; Dekker, JW; Delgado Bolton, R; Fléjou, JF; Grisold, W; Henning, G; Laghi, A; Lovey, J; Negrouk, A; Pereira, P; Roca, P; Saarto, T; Seufferlein, T; Taylor, C; Ugolini, G; Velde, CV; Herck, BV; Yared, W; Costa, A; Naredi, P ECCO Essential Requirements for Quality Cancer Care: Colorectal Cancer. A critical review.
Crit Rev Oncol Hematol. 2017; 110(5):81-93 Doi: 10.1016/j.critrevonc.2016.12.001 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Eisterer, W; Piringer, G; DE Vries, A; Öfner, D; Greil, R; Tschmelitsch, J; Samonigg, H; Sölkner, L; Gnant, M; Thaler, J; Austrian Breast and Colorectal Cancer Study Group Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Anticancer Res. 2017; 37(5):2683-2691 Doi: 10.21873/anticanres.11617 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Lugli, A; Kirsch, R; Ajioka, Y; Bosman, F; Cathomas, G; Dawson, H; El Zimaity, H; Fléjou, JF; Hansen, TP; Hartmann, A; Kakar, S; Langner, C; Nagtegaal, I; Puppa, G; Riddell, R; Ristimäki, A; Sheahan, K; Smyrk, T; Sugihara, K; Terris, B; Ueno, H; Vieth, M; Zlobec, I; Quirke, P Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.
Mod Pathol. 2017; 30(9):1299-1311 Doi: 10.1038/modpathol.2017.46 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Dahlhaus, A; Semlitsch, T; Jeitler, K; Horvath, K; Siebenhofer, A Relevance to family practice of English-language guidelines on breast, colorectal and prostate cancer: a review.
Fam Pract. 2015; 32(5):483-491 Doi: 10.1093/fampra/cmv053 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Jacobsen, PB; Lee, JH; Fulp, W; Siegel, EM; Shibata, D; Laronga, C; Gray, J; Tanvetyanon, T; Schreiber, F; Brown, R; Levine, R; Cartwright, T; Abesada-Terk, G; Kim, G; Alemany, C; Faig, D; Sharp, P; Markham, MJ; Malafa, M Florida Initiative for Quality Cancer Care: Changes in Psychosocial Quality of Care Indicators Over a 3-Year Interval.
J Oncol Pract. 2015; 11(1):e103-e109 Doi: 10.1200/JOP.2014.001525 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ress, AL; Perakis, S; Pichler, M microRNAs and Colorectal Cancer.
Adv Exp Med Biol. 2015; 889(6):89-103 Doi: 10.1007/978-3-319-23730-5_6
Web of Science PubMed FullText FullText_MUG

 

2014

Eisterer, W; De Vries, A; Öfner, D; Rabl, H; Koplmüller, R; Greil, R; Tschmelitsch, J; Schmid, R; Kapp, K; Lukas, P; Sedlmayer, F; Höfler, G; Gnant, M; Thaler, J; Austrian Breast and Colorectal Cancer Study Group (ABCSG) Preoperative treatment with capecitabine, cetuximab and radiotherapy for primary locally advanced rectal cancer--a phase II clinical trial.
Anticancer Res. 2014; 34(11):6767-6773
Web of Science PubMed FullText

 

2012

Betge, J; Schneider, NI; Pollheimer, MJ; Lindtner, RA; Kornprat, P; Schlemmer, A; Rehak, P; Langner, C Is there a rationale to record lymphatic invasion in node-positive colorectal cancer?
J Clin Pathol. 2012; 65(9):847-850 Doi: 10.1136/jclinpath-2012-200817
Web of Science PubMed FullText FullText_MUG

 

Harbaum, L; Pollheimer, MJ; Kornprat, P; Lindtner, RA; Schlemmer, A; Rehak, P; Langner, C Keratin 20 - a diagnostic and prognostic marker in colorectal cancer?
Histol Histopathol. 2012; 27(3):347-356
Web of Science PubMed

 

2011

Kornprat, P; Pollheimer, MJ; Lindtner, RA; Schlemmer, A; Rehak, P; Langner, C Value of tumor size as a prognostic variable in colorectal cancer: a critical reappraisal.
Am J Clin Oncol. 2011; 34(1):43-49 Doi: 10.1097/COC.0b013e3181cae8dd
Web of Science PubMed FullText FullText_MUG

 

2009

Silberhumer, GR; Zakian, K; Malhotra, S; Brader, P; Gönen, M; Koutcher, J; Fong, Y Relationship between 31P metabolites and oncolytic viral therapy sensitivity in human colorectal cancer xenografts.
Br J Surg. 2009; 96(7):809-816 Doi: 10.1002/bjs.6604
Web of Science PubMed FullText FullText_MUG

 

2007

Tomlinson, JS; Jarnagin, WR; DeMatteo, RP; Fong, Y; Kornprat, P; Gonen, M; Kemeny, N; Brennan, MF; Blumgart, LH; D'Angelica, M Actual 10-year survival after resection of colorectal liver metastases defines cure.
J Clin Oncol. 2007; 25(29):4575-4580 Doi: 10.1200/JCO.2007.11.0833 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2003

Fuchsjager, MH; Maier, AG; Schima, W; Zebedin, E; Herbst, F; Mittlbock, M; Wrba, F; Lechner, GL Comparison of transrectal sonography and double-contrast MR imaging when staging rectal cancer
AJR Am J Roentgenol. 2003; 181(2):421-427 Doi: 10.2214/ajr.181.2.1810421
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1999

Samonigg, H; Wilders-Truschnig, M; Kuss, I; Plot, R; Stöger, H; Schmid, M; Bauernhofer, T; Tiran, A; Pieber, T; Havelec, L; Loibner, H A double-blind randomized-phase II trial comparing immunization with antiidiotype goat antibody vaccine SCV 106 versus unspecific goat antibodies in patients with metastatic colorectal cancer.
J Immunother. 1999; 22(6):481-488 Doi: 10.1097/00002371-199911000-00002
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1998

Lode, HN; Xiang, R; Becker, JC; Gillies, SD; Reisfeld, RA Immunocytokines: a promising approach to cancer immunotherapy.
Pharmacol Ther. 1998; 80(3):277-292 Doi: 10.1016/S0163-7258(98)00033-3
Web of Science PubMed FullText FullText_MUG

 

1992

Samonigg, H; Wilders-Truschnig, M; Loibner, H; Plot, R; Rot, A; Kuss, I; Werner, G; Stöger, H; Wrann, M; Herlyn, D Immune response to tumor antigens in a patient with colorectal cancer after immunization with anti-idiotype antibody.
Clin Immunol Immunopathol. 1992; 65(3):271-277 Doi: 10.1016/0090-1229(92)90157-J (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum